In a recent small study published in the International Journal of Cancer, researchers found that a single, brief bout of ...

Most health advice circles back to the same message: protect your heart. From blood pressure and cholesterol to diet and ...

Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a ...

SAN FRANCISCO -- Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower mortality and ...

A mere 10 minutes of daily physical activity could potentially safeguard the body from cancer. Recent research has revealed ...

The benefit of PARP inhibitors varied significantly based on the tumor's molecular profile, particularly its homologous recombination repair capability. While patients with deficiencies in this ...

New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...

Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...

"Seven in 10 people now survive their cancer 5 years or more, up from only half in the mid-70s," Siegel said in a press ...

First-line zanidatamab plus chemotherapy leads to ‘practice-changing’ PFS and overall survival gains in a phase 3 study of ...

When Jayant Parthasarathy lost family members to breast, brain, ovarian, and prostate cancers, his next mission was clear.

A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...